11.07.2015 Views

Prescribed Drugs Provider Manual - Iowa Department of Human ...

Prescribed Drugs Provider Manual - Iowa Department of Human ...

Prescribed Drugs Provider Manual - Iowa Department of Human ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Iowa</strong><strong>Department</strong><strong>of</strong> <strong>Human</strong>Services<strong>Provider</strong> and Chapter<strong>Prescribed</strong> <strong>Drugs</strong>Chapter III. <strong>Provider</strong>-Specific PoliciesPage10DateAugust 1, 2013♦ Plan limits exceeded. Refer to the limits list posted on the website, www.iowamedicaidpdl.com, under “Billing/Quantity Limits.” Thenumber <strong>of</strong> doses should be reduced to meet the quantity limit.If there are special circumstances where adherence to the quantitylimit is not possible, the prescriber should complete form 470-4556,Quantity Limit Override, or form 470-5038, Request for Fifteen DayInitial Prescription Supply Override, and fax it to 1-800-574-2515.The clinical staff will review the information submitted and determineif an override can be given to allow payment.If the member or caregiver is not satisfied with the explanation <strong>of</strong> thereason for a denial, refer the person to the member’s DHS worker forassistance in filing an appeal or requesting an exception to policy.Appeal and exception requests may be filed on line through thefollowing web site: http://www.dhs.state.ia.us/dhs/appeals/.5. Drug Use ReviewThe drug use review (DUR) process was established to fulfill a federalrequirement established by the federal Omnibus Budget Reconciliation Act <strong>of</strong>1990. <strong>Iowa</strong> Medicaid has implemented both <strong>of</strong> the required DUR types:♦ Prospective drug utilization review occurs when the pharmacist doesthe review <strong>of</strong> patient drug therapy at the point <strong>of</strong> sale. See PharmacistResponsibilities.♦ Retrospective drug utilization review occurs when the review takesplace after the point <strong>of</strong> sale.The retrospective DUR program provides ongoing periodic examination <strong>of</strong>claims data and other records in order to identify patterns <strong>of</strong> fraud, abuse,gross overuse, or inappropriate or medically unnecessary care amongphysicians, pharmacists, and members, or associated with specific drugs.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!